Psychotropic Medication Monitoring in a Human Services Organization for Children with Autism Spectrum Disorder: Description and Evaluation of Interdisciplinary Team Review.
Frank BirdJill M HarperJames K LuiselliAndrew ShlesingerJoseph GoldPublished in: Behavior analysis in practice (2022)
Children with autism spectrum disorder (ASD) are often prescribed psychotropic medications but pharmacotherapy is typically conducted and evaluated based on clinical judgement without reference to objective measurement of treatment effectiveness and combined efficacy of pharmacological-behavioral interventions. We describe an interdisciplinary review team (IRT) model at a human services organization for children with ASD that was designed to standardize a process of psychotropic medication monitoring through (1) coordinated involvement of medical, nursing, behavior analyst, and special education professionals, (2) parent-guardian participation, (3) data-driven decision making, and (4) high-level administrative support. Our description includes case illustrations of medication reduction-elimination trials with five students and social validity assessment of IRT clinicians, nurses, and parent-guardians. Key components of the IRT model are emphasized with associated practice and research recommendations.
Keyphrases
- healthcare
- endothelial cells
- mental health
- autism spectrum disorder
- palliative care
- quality improvement
- decision making
- primary care
- physical activity
- induced pluripotent stem cells
- randomized controlled trial
- pluripotent stem cells
- young adults
- attention deficit hyperactivity disorder
- systematic review
- intellectual disability
- adverse drug
- affordable care act
- electronic health record
- replacement therapy